Creo Medical Limited
CREO.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £56 | £71 | £121 | £165 |
| - Cash | £21 | £9 | £10 | £3 |
| + Debt | £4 | £4 | £14 | £8 |
| Enterprise Value | £40 | £66 | £126 | £171 |
| Revenue | £2 | – | £15 | £15 |
| % Growth | – | – | 0.7% | – |
| Gross Profit | £1 | – | £7 | £8 |
| % Margin | 45.5% | – | 47.4% | 51.7% |
| EBITDA | -£10 | – | -£12 | -£9 |
| % Margin | -431.8% | – | -77.6% | -61.6% |
| Net Income | £17 | – | -£12 | -£10 |
| % Margin | 768.2% | – | -80.9% | -66.9% |
| EPS Diluted | 0.041 | – | -0.034 | -0.028 |
| % Growth | – | – | -21% | – |
| Operating Cash Flow | £15 | £0 | -£14 | -£6 |
| Capital Expenditures | £0 | £0 | -£1 | -£1 |
| Free Cash Flow | £15 | £0 | -£14 | -£7 |